Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of DENN/MADD domain containing 1A variant 2 (DENND1A variant 2)

Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of DENN/MADD domain containing 1A variant 2 (DENND1A variant 2)

US Patent 10723790 · Granted Jul 28, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods relating to DENND1A variant 2 and polycystic ovary synd2020
Compositions and methods relating to DENND1A variant 2 and polycystic ovary synd2020
Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A va2019
Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A va2019
Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A va2019
Compositions and methods for targeting of the surfactant protein A receptor2018
Methods relating to DENND1A Variant 2 and polycystic ovary syndrome2018
Methods relating to DENND1A Variant 2 and polycystic ovary syndrome2018
Pharmaceutical compositions comprising DENND1A variant 2 and methods of use ther2017
Pharmaceutical compositions comprising DENND1A variant 2 and methods of use ther2017
Pharmaceutical compositions comprising DENND1A variant 2 and methods of use ther2017
Identification and characterization of a specific CCK-C receptor antibody for hu2014